197 related articles for article (PubMed ID: 19449367)
1. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
[TBL] [Abstract][Full Text] [Related]
2. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.
Mariani O; Brennetot C; Coindre JM; Gruel N; Ganem C; Delattre O; Stern MH; Aurias A
Cancer Cell; 2007 Apr; 11(4):361-74. PubMed ID: 17418412
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.
Saâda-Bouzid E; Burel-Vandenbos F; Ranchère-Vince D; Birtwisle-Peyrottes I; Chetaille B; Bouvier C; Château MC; Peoc'h M; Battistella M; Bazin A; Gal J; Michiels JF; Coindre JM; Pedeutour F; Bianchini L
Mod Pathol; 2015 Nov; 28(11):1404-14. PubMed ID: 26336885
[TBL] [Abstract][Full Text] [Related]
4. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
Hisaoka M; Matsuyama A; Nakamoto M
Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
6. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.
Louis-Brennetot C; Coindre JM; Ferreira C; Pérot G; Terrier P; Aurias A
Genes Chromosomes Cancer; 2011 Nov; 50(11):896-907. PubMed ID: 21910158
[TBL] [Abstract][Full Text] [Related]
7. ASK1 (MAP3K5) as a potential therapeutic target in malignant fibrous histiocytomas with 12q14-q15 and 6q23 amplifications.
Chibon F; Mariani O; Derré J; Mairal A; Coindre JM; Guillou L; Sastre X; Pédeutour F; Aurias A
Genes Chromosomes Cancer; 2004 May; 40(1):32-7. PubMed ID: 15034865
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
10. Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.
Sirvent N; Coindre JM; Maire G; Hostein I; Keslair F; Guillou L; Ranchere-Vince D; Terrier P; Pedeutour F
Am J Surg Pathol; 2007 Oct; 31(10):1476-89. PubMed ID: 17895748
[TBL] [Abstract][Full Text] [Related]
11. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
12. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.
Lee SE; Kim YJ; Kwon MJ; Choi DI; Lee J; Cho J; Seo SW; Kim SJ; Shin YK; Choi YL
Histol Histopathol; 2014 Jan; 29(1):127-38. PubMed ID: 23852861
[TBL] [Abstract][Full Text] [Related]
13. Selective elimination of amplified CDK4 sequences correlates with spontaneous adipocytic differentiation in liposarcoma.
Hélias-Rodzewicz Z; Pédeutour F; Coindre JM; Terrier P; Aurias A
Genes Chromosomes Cancer; 2009 Nov; 48(11):943-52. PubMed ID: 19626636
[TBL] [Abstract][Full Text] [Related]
14. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma.
Horvai AE; DeVries S; Roy R; O'Donnell RJ; Waldman F
Mod Pathol; 2009 Nov; 22(11):1477-88. PubMed ID: 19734852
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
17. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas.
Schneider-Stock R; Boltze C; Jaeger V; Stumm M; Seiler C; Rys J; Schütze K; Roessner A
J Pathol; 2002 Aug; 197(5):654-60. PubMed ID: 12210086
[TBL] [Abstract][Full Text] [Related]
18. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
19. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346
[TBL] [Abstract][Full Text] [Related]
20. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors.
Ware PL; Snow AN; Gvalani M; Pettenati MJ; Qasem SA
Am J Clin Pathol; 2014 Mar; 141(3):334-41. PubMed ID: 24515760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
